Wire by Fusion42
Fusion42 Scout Raise
The Debrief & Outliers
Regulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers
Benchmarks
Benchmarks HomeBy News TypeBy RegionBy Sector
AI WeeklyAbout

Switch product

Fusion42RaiseScoutWire

The Debrief & Outliers

All editionsRegulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers

Database & benchmarks

Benchmarks HomeBy News TypeBy RegionBy SectorStories

Account

Sign in
← Back

Wire · operational-macro

Bausch + Lomb CEO Saunders departs, Chairman Appio named interim chief

12 October 2026 · By · Wire by Fusion42

Published

12 October 2026

Topic

operational-macro

◆ Sectors

Health

◆ Geography

United States

◆ Source

Read at whtc.com →

◆ Verified

Fusion42 · 12 October 2026 · Fusion42 review

Bausch + Lomb CEO Brent Saunders is leaving the company by mutual agreement, with Chairman Thomas Appio named as interim CEO. This management change caused the company's shares to drop over 7%, and it comes amid plans to raise 2026 adjusted EBITDA forecasts.

This Wire brief sits within Fusion42's coverage of Health, and 3 sources have reported it.

◆ ◆ The Wire takeaway

Leadership instability at a major eye-care company signals uncertainty in the health sector; you need to watch for potential shifts in partnerships or investor appetite that could open new opportunities or create risks.

◆ Coverage

3 sources · 12 Oct 2026

◆ Related on Wire

◆ Topics

Healthceo-exitexecutive-changehealthcareus-marketstock-impact